Dr. Raman Tuli

Participates in 5 items

Sessions in which Dr. Raman Tuli participates

Saturday 26 June, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

Faricimab in Neovascular Age-Related Macular Degeneration: One-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials

15:51 - 15:59 | 8 minutes

Dr. Raman Tuli (Speaker)

Sunday 27 June, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab(PDS) for Patients With Neovascular AMD

16:07 - 16:15 | 8 minutes

Dr. Raman Tuli (Speaker)

Friday 16 June, 2023

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

Efficacy of intravitreal pegcetacoplan in geographic atrophy: 24-month results from the Phase 3 OAKS and DERBY trials

13:46 - 13:53 | 7 minutes

Québec City Convention Centre - Room 307 AB | Salle 307 AB

Dr. Raman Tuli (Presenter)

Friday 20 June, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

Long-Term Efficacy and Safety of Pegcetacoplan Over 36 Months Including 12-Month Results of the GALE Open-Label Extension Study - 5561

11:32 - 11:37 | 5 minutes

Vancouver Convention Centre (East Building) - Ballroom B

Dr. Raman Tuli (Speaker)

11:37 - 11:40 | 3 minutes

Vancouver Convention Centre (East Building) - Ballroom B